Displaying 1 - 1 of 1
| Active Ingredient | CARBOPLATIN |
| Therapeutic Class | ANTINEOPLASTICS |
| Indications | Advanced ovarian cancers and of small-cell lung cancer. |
| Caution | As for cisplatin. Myelosuppression may be more severe than cisplatin and prolonged in patients with impaired renal function. |
| Dose Range | Adult: dose of carboplatin is determined according to renal function rather than body surface area. |
| Drug Interactions | |
| Pregnancy | Carboplatin can cause fetal toxicity when administered to pregnant women, but po More ... |
| Breast Feeding | Because of the potential for serious adverse reactions to carboplatin in nursing More ... |